The $100 Billion Deal Is Still Out There For Pharma
Why stop at $221 billion? Drug companies are entering another round of dealmaking, after plowing past the global record.
Teva Pharmaceutical Industries Ltd.’s $40.5 billion agreement Monday to purchase Allergan Plc’s generic-medicines business puts the mechanism in place to trigger more takeovers.
Hey, check out all the research scientist jobs. Post your resume today!
Hey, check out all the research scientist jobs. Post your resume today!